Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Bayer's Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients
The decision covers its use in cardiac magnetic resonance imaging to determine patient levels of myocardial perfusion and late gadolinium...
FDA and EMA fully implement mutual recognition agreement between US and EU
The FDA has recognised Slovakia’s ability to carry out inspections of manufacturing facilties.
AstraZeneca's Farxiga fails to get FDA approval for patients with Type 1 diabetes
The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in adults with Type 1 diabetes who...
GSK's Zejula meets primary endpoint in Phase 3 trial of patients with ovarian cancer
British multinational GlaxoSmithKline has said ovarian cancer drug Zejula (niraparib) met its primary endpoint in a Phase 3 trial.
>> More Sales and Marketing News Stories

Features

Darius Hughes, Head of Vaccines Business Unit UK, Pfizer

“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” - Darius Hughes, Head of Vaccines Business...

>> More Features

Appointments

GSK hires computational drug design expert Dr Kim Branson as new head of machine learning and AI

British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President,...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches